5
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Gallbladder Function in Acromegalic Patients Taking Long-Term Octreotide: Evidence of Rebound Hypermotility on Cessation of Treatment

, , , , &
Pages 115-118 | Received 10 Jul 1991, Accepted 13 Aug 1991, Published online: 05 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Renato Cozzi & Roberto Attanasio. (2012) Octreotide long-acting repeatable for acromegaly. Expert Review of Clinical Pharmacology 5:2, pages 125-143.
Read now

Articles from other publishers (14)

Nashiz Inayet, Jamal Hayat, Gul Bano & Andrew Poullis. (2020) Gastrointestinal symptoms in acromegaly: A case control study. World Journal of Gastrointestinal Pharmacology and Therapeutics 11:2, pages 17-24.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 427 437 .
R. Attanasio, A. Mainolfi, F. Grimaldi, R. Cozzi, M. Montini, C. Carzaniga, S. Grottoli, L. Cortesi, M. Albizzi, R. M. Testa, L. Fatti, D. De Giorgio, C. Scaroni, F. Cavagnini, P. Loli, G. Pagani & E. Ghigo. (2014) Somatostatin analogs and gallstones: A retrospective survey on a large series of acromegalic patients. Journal of Endocrinological Investigation 31:8, pages 704-710.
Crossref
A. N. Paisley, M. E. Roberts & P. J. Trainer. (2007) Withdrawal of somatostatin analogue therapy in patients with acromegaly is associated with an increased risk of acute biliary problems. Clinical Endocrinology 66:5, pages 723-726.
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 3160 3163 .
M E Lucarotti, J A Hamilton & J R Farndon. (1994) Somatostatin and primary hyperparathyroidism. British Journal of Surgery 81:8, pages 1141-1143.
Crossref
Connie B. Newman. (1999) MEDICAL THERAPY FOR ACROMEGALY. Endocrinology and Metabolism Clinics of North America 28:1, pages 171-190.
Crossref
Michael C. Trendle, Charles G. Moertel & Larry K. Kvols. (2000) Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors. Cancer 79:4, pages 830-834.
Crossref
S H Hussaini, S P Pereira, M J Veysey, C Kennedy, P Jenkins, G M Murphy, J A Wass & R H Dowling. (1996) Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones.. Gut 38:5, pages 775-783.
Crossref
CARLOS A. BUCHPIGUEL, MARCELO T. SAPIENZA, DENISE P. VEZZOZZO, ROBERTO ROCKMAN, GIOVANNI G. CERRI & ALVARO E. A. MAGALHãES. (1996) Gallbladder Emptying in Normal Volunteers. Clinical Nuclear Medicine 21:3, pages 208-212.
Crossref
S. A. JENKINS & A. BEREIN. (2007) The relative effectiveness of somatostatin and octreotide therapy in pancreatic disease. Alimentary Pharmacology & Therapeutics 9:4, pages 349-361.
Crossref
J. A. McKnight, D. R. McCance, J. G. Crothers, E. M. Mcllrath & A. B. Atkinson. (1994) Incidence and medical treatment of octreotide induced gallstones in subjects with resistant acromegaly: A prospective study. Irish Journal of Medical Science 163:1, pages 25-27.
Crossref
J.R. Peters. 1993. 494 509 .
Alan G. Harris. (2012) Octreotide in the Treatment of Disorders of the Gastrointestinal System. Drug Investigation 4:S3, pages 1-54.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.